HRSA Launches Framework to Modernize National Newborn Screening Panel Review Process
The Health Resources and Services Administration announced a new framework on August 11, 2026, to streamline how conditions are evaluated for addition to the national newborn screening panel. The initiative aims to update a review process that officials say has not kept pace with advances in genetic medicine. The framework establishes a standardized pathway for assessing which screenable conditions should be recommended for inclusion. This affects state Medicaid programs and CHIP, which finance newborn screening for the majority of U.S. births and must determine coverage for newly recommended tests.
State Medicaid agencies will need to assess budget and administrative implications as new conditions are added to recommended screening protocols, potentially triggering EPSDT coverage requirements and raising costs for testing and follow-up diagnostic services.
Maternal · CHIP
You might also like